APA-viite (7. p.)

Cao Y, Li Y, Han W, Jia X, Zhu P, Wei B, . . . Wang Z. (2023). Sodium Butyrate Ameliorates Type 2 Diabetes-Related Sarcopenia Through IL-33-Independent ILC2s/IL-13/STAT3 Signaling Pathway. Dove Medical Press.

Chicago-viite (17. p.)

Cao Y, Li Y, Han W, Jia X, Zhu P, Wei B, Cong X, ja Wang Z. Sodium Butyrate Ameliorates Type 2 Diabetes-Related Sarcopenia Through IL-33-Independent ILC2s/IL-13/STAT3 Signaling Pathway. Dove Medical Press, 2023.

MLA-viite (9. p.)

Cao Y, et al. Sodium Butyrate Ameliorates Type 2 Diabetes-Related Sarcopenia Through IL-33-Independent ILC2s/IL-13/STAT3 Signaling Pathway. Dove Medical Press, 2023.